| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.001 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.002 |